The pioneering digital pharmaceutical distribution platform i’SUPPLY has raised USD 2.5 million since its 2022 founding. Major investors like Disruptech Ventures, OneStop Capital, Axian Investment CVC, and Egypt Ventures participated in the funding round.
Through its tech-enabled platform, i’SUPPLY supports pharmacies and small to medium-sized distribution enterprises in Egypt. The company executes over one million purchase orders and has an estimated EGP 1 billion in transaction volume since its start.
Read also – India-Based Battery Smart Secures $65 Million in Series B Round Funding
The integrated network serves over 10,000 pharmacies and works with over 200 distribution partners to offer over 10,000 pharmaceutical items. Compared to 2023, it’s transactions and revenue increased fivefold from January to May 2024.
Commenting on the latest funding round, Ibrahim Emam, CEO and Co-Founder of i’SUPPLY, stated, “This investment marks a leap forward for us, as it accelerates our growth strategy and revolutionizes our ability to empower small and medium-sized pharmacies. Our sights are set even higher as we strive to obtain a license from the Egyptian Financial Regulatory Authority to meet the evolving financing needs of small and medium-sized pharmacies. Our unwavering commitment to meeting the escalating market demand for funding, addressing working capital shortages among pharmacies and small distributors, remains at the core of our mission.”
Under 18 months, i’SUPPLY reached profitability, demonstrating its operational efficiency and capital management. Upon licencing, this pre-series A capital round will boost i’SUPPLY’s expansion goals and ability to finance small and medium-sized pharmacies.
Read also – Saudi Arabia-Based Tahdir Secures 306K in Pre-Seed Funding
Additionally, the company will improve its fintech solutions and technical services for pharmaceutical makers, distributors, pharmacies, and private and public hospitals.
About i’SUPPLY
i’SUPPLY is a pharmaceutical sector B2B multi-seller marketplace that digitises and optimises supply and demand transactions between medicine producers, distributors, wholesalers, and pharmacies.
